Guardian Pharmacy Services, Inc. — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 12/100
What the filing says
Filing contains blank-template exhibits: (1) Nonqualified Stock Option Agreement under 2024 Equity Plan with 3-year cliff vesting and 10-year term; (2) Executive Employment Agreement template with 2-year initial term, at-will employment, severance of 2x base+bonus (3x if Change in Control within 2 years), 2-year non-compete covering continental U.S., and clawback provisions. No specific option grants, share counts, dollar amounts, or named counterparties are disclosed—all terms are bracketed placeholders. SOX 302/906 certifications by CEO Fred P. Burke and CFO William Mudd dated August 6, 2026 attest to Q2 2026 10-Q accuracy.
Why this rating
Routine template disclosure; no actual transactions, no material financial or operational change; administrative exhibit to equity plan.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.